Calidi Biotherapeutics, Inc. Common Stock CLDI 深 滬
等待開盤 07-19 09:30:00 美东时间
0.6072
-0.009
-1.41%
華盛通- 最 高0.6432
- 今 開0.5695
- 成交量 231.35万股
- 最 低 0.5695
- 昨 收 0.6159
- 總市值 1930.45万
- 52周最高 3.89
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 0.2027
- 委 比 -33.33%
- 總股本 3179.26万
- 歷史最高 240.50
- 量 比 0.39
- 振 幅 11.97%
- 歷史最低 0.2027
- 每 手 1
- 風險率 0.56%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 151.2% to $3.04 duri...
07-18 20:07
Calidi Biotherapeutics Announces Inducement Offer Agreement
Calidi Biotherapeutics ( ($CLDI) ) has shared an announcement. On July 9, 2025,...
07-11 01:27
Calidi Biotherapeutics Announces Exercise Of ~6.6M Warrants At $0.70, Raising $4.6M In Gross Proceeds
Calidi Biotherapeutics, Inc. ("Calidi" or the "Company") (NYSE:CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal
07-10 02:08
Why Is Calidi Biotherapeutics Stock (CLDI) Up 170% Today?
Calidi Biotherapeutics stock soared after its genetic cancer treatment was feat...
07-09 20:48
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the di...
07-09 20:30
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds
Calidi Biotherapeutics executed existing warrants to raise approximately $4.6 million by issuing new warrants exercisable at $0.70 per share, six months post-issuance, with a five-and-a-half-year term. Proceeds will fund clinical and pre-clinical programs and operating expenses. Ladenburg Thalmann serves as the placement agent. The offering is expected to close on July 10, 2025, subject to customary conditions. The new warrants and underlying sha...
07-09 18:01
Why AES Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover interest.
07-09 17:00
Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On
Calidi Biotherapeutics (NYSE: CLDI) surged 39.47% after hours Tuesday, following renewed investor interest in its innovative cancer treatment developments.
07-09 12:09
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
Calidi Biotherapeutics Inc. announced the publication of an editorial highlighting its precision genetic medicine platform for treating metastatic cancer. With an annual estimate of 20 million cancer diagnoses worldwide and significant market potential for new therapies, Calidi's innovative approach uses engineered viruses to deliver genetic medicines directly to tumors, potentially revolutionizing cancer treatment. The company, headquartered in ...
07-08 12:30
Calidi Biotherapeutics Announces Shareholder Letter from CEO
Calidi Biotherapeutics Inc. (CLDI) reported significant progress in 2025, including leadership changes, cost reductions, and advancements in its R&D pipeline. The company highlighted the rapid development of its RedTail platform, which delivers genetic medicines to metastatic cancer sites using an engineered enveloped virus. Recent preclinical data at AACR and ASCO meetings demonstrated RedTail's tumor-selective targeting and immune modulation ca...
06-27 12:00
